These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19563647)

  • 1. High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India.
    D'souza DT; Mistry NF; Vira TS; Dholakia Y; Hoffner S; Pasvol G; Nicol M; Wilkinson RJ
    BMC Public Health; 2009 Jun; 9():211. PubMed ID: 19563647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of multi drug resistant tuberculosis in people living with HIV in Western India.
    Saldanha N; Runwal K; Ghanekar C; Gaikwad S; Sane S; Pujari S
    BMC Infect Dis; 2019 May; 19(1):391. PubMed ID: 31068153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a comprehensive programme to provide universal access to care for sputum-smear-positive multidrug-resistant tuberculosis in China: a before-and-after study.
    Li R; Ruan Y; Sun Q; Wang X; Chen M; Zhang H; Zhao Y; Zhao J; Chen C; Xu C; Su W; Pang Y; Cheng J; Chi J; Wang Q; Fu Y; Huan S; Wang L; Wang Y; Chin DP
    Lancet Glob Health; 2015 Apr; 3(4):e217-28. PubMed ID: 25794675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug-resistant TB among previously treated TB cases: A retrospective study in Nagpur, India.
    Munje R; Deshmukh R; Tumane K
    Indian J Tuberc; 2015 Oct; 62(4):207-10. PubMed ID: 26970460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial drug resistance pattern among pulmonary tuberculosis patients.
    Gupta H; Kant S; Jain A; Natu SM; Ahluwalia S
    Indian J Tuberc; 2013 Jul; 60(3):154-61. PubMed ID: 24000493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alarming levels of drug-resistant tuberculosis in HIV-infected patients in metropolitan Mumbai, India.
    Isaakidis P; Das M; Kumar AM; Peskett C; Khetarpal M; Bamne A; Adsul B; Manglani M; Sachdeva KS; Parmar M; Kanchar A; Rewari BB; Deshpande A; Rodrigues C; Shetty A; Rebello L; Saranchuk P
    PLoS One; 2014; 9(10):e110461. PubMed ID: 25333696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active case finding of rifampicin sensitive and resistant TB among household contacts of drug resistant TB patients in Andhra Pradesh and Telangana states of India - A systematic screening intervention.
    Chatla C; Jaju J; Achanta S; Samyuktha R; Chakramahanti S; Purad C; Chepuri R; Nair SA; Parmar M
    Indian J Tuberc; 2018 Jul; 65(3):218-224. PubMed ID: 29933863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance mutations and heteroresistance detected using the GenoType MTBDRplus assay and their implication for treatment outcomes in patients from Mumbai, India.
    Tolani MP; D'souza DT; Mistry NF
    BMC Infect Dis; 2012 Jan; 12():9. PubMed ID: 22260344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First and second line drug resistance among treatment naïve pulmonary tuberculosis patients in a district under Revised National Tuberculosis Control Programme (RNTCP) in New Delhi.
    Myneedu VP; Singhal R; Khayyam KU; Sharma PP; Bhalla M; Behera D; Sarin R
    J Epidemiol Glob Health; 2015 Dec; 5(4):365-73. PubMed ID: 25944154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?
    Dave P; Vadera B; Kumar AM; Chinnakali P; Modi B; Solanki R; Patel P; Patel P; Pujara K; Nimavat P; Shah A; Bharaswadkar S; Rade K; Parmar M; Nair SA
    PLoS One; 2015; 10(4):e0121996. PubMed ID: 25874545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High degree of fluoroquinolone resistance among pulmonary tuberculosis patients in New Delhi, India.
    Sharma R; Sharma SK; Singh BK; Mittal A; Kumar P
    Indian J Med Res; 2019 Jan; 149(1):62-66. PubMed ID: 31115377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for new pulmonary tuberculosis patients failing treatment under the Revised National Tuberculosis Control Programme, India.
    Singla R; Srinath D; Gupta S; Visalakshi P; Khalid UK; Singla N; Gupta UA; Bharty SK; Behera D
    Int J Tuberc Lung Dis; 2009 Apr; 13(4):521-6. PubMed ID: 19335960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low prevalence of MDR-TB in Lao PDR: results from the first national anti-tuberculosis drug resistance survey.
    Iem V; Dean A; Zignol M; Vongvichit P; Inthavong D; Siphanthong S; Sorsavanh T; Kim SJ; Shin S; Sébert J; Chittamany P
    Trop Med Int Health; 2019 Apr; 24(4):421-431. PubMed ID: 30663180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
    Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
    Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.
    Parmar MM; Sachdeva KS; Dewan PK; Rade K; Nair SA; Pant R; Khaparde SD
    PLoS One; 2018; 13(4):e0193903. PubMed ID: 29641576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends of anti-tuberculosis drug resistance pattern in new cases and previously treated cases of extrapulmonary tuberculosis cases in referral hospitals in northern India.
    Maurya AK; Kant S; Nag VL; Kushwaha RA; Dhole TN
    J Postgrad Med; 2012; 58(3):185-9. PubMed ID: 23023350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment.
    Coronel J; Roper MH; Herrera C; Bonilla C; Jave O; Gianella C; Sabogal I; Huancaré V; Leo E; Tyas A; Mendoza-Ticona A; Caviedes L; Moore DA
    Clin Microbiol Infect; 2014 Jun; 20(6):536-41. PubMed ID: 24107197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of multidrug-resistant tuberculosis among newly diagnosed cases of sputum-positive pulmonary tuberculosis.
    Sharma SK; Kaushik G; Jha B; George N; Arora SK; Gupta D; Singh U; Hanif M; Vashisht RP
    Indian J Med Res; 2011 Mar; 133(3):308-11. PubMed ID: 21441685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.